Chemipharm

Chemipharm, established in 1972, operates as a prominent player in the pharmaceutical and healthcare sectors. As the first private sector importer of pharmaceutical products in Egypt, the company has built a reputation for high-standard distribution. Its strategic focus centers on continuous improvement and growth within the competitive pharmaceutical landscape, maintaining a strong commitment to quality and regulatory compliance.

The company maintains a robust operational footprint, including a modern GMP-certified manufacturing facility located in the 6th of October Industrial Zone. This plant produces diverse pharmaceutical forms, such as tablets, capsules, syrups, and ointments. Chemipharm manages an extensive distribution network across Egypt, utilizing 12 branches and 100 daily fixed routes to reach pharmacies and hospitals. The organization is currently expanding its technical capabilities by constructing a new sterile area dedicated to the production of ampoules, eye drops, and antibiotics.

With an annual revenue of $709.1M and a workforce of 1,000-5,000 employees, Chemipharm maintains a significant market presence. The company competes with major industry entities like Teva and Alvogen, leveraging its deep penetration into the Egyptian market. Meet Chemipharm's team to understand the leadership driving these operations. The firm continues to prioritize technical excellence and infrastructure development to sustain its long-term growth trajectory in the global pharmaceutical market.